Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/27/2025

Treatment of Chronic Severe Bloating with Abdominal Pain

Initial Diagnostic Workup

  • The American Gastroenterological Association recommends checking tissue transglutaminase IgA and total IgA levels to exclude celiac disease, which commonly presents with bloating and pain 1, 3, 4
  • The European Society for Pediatric Gastroenterology, Hepatology and Nutrition suggests obtaining fecal calprotectin if diarrhea is present and age <45 years to rule out inflammatory bowel disease (IBD) 4
  • Assess for alarm symptoms including weight loss >10%, GI bleeding, family history of IBD, or recent worsening nausea—these require urgent evaluation with endoscopy and/or imaging 1, 2, 3
  • Screen for SIBO risk factors including prior GI surgery, chronic watery diarrhea, malnutrition, systemic diseases causing dysmotility, or loss of ileocecal valve 1, 2, 5

First-Line Treatment: Dietary Intervention

  • The British Dietetic Association recommends implementing a low-FODMAP diet for 4-6 weeks as the initial therapeutic intervention, addressing carbohydrate intolerance and reducing fermentable substrate for bacterial overgrowth 1, 2, 6
  • A dietitian must supervise the low-FODMAP diet to ensure nutritional adequacy, particularly important given risk of malnutrition with restrictive diets 7, 8, 9
  • In patients with self-reported gluten sensitivity, fructans rather than gluten often cause symptoms—consider eliminating fructans specifically 1, 3, 8
  • Hydrogen-methane breath testing can identify specific carbohydrate intolerances to guide targeted dietary restriction 2, 5

Second-Line Treatment: Rifaximin for SIBO

  • The American College of Gastroenterology recommends treating empirically with rifaximin 550 mg three times daily for 14 days if dietary intervention fails 1, 2
  • Rifaximin demonstrates a 38% response rate for combined abdominal pain and stool consistency improvement versus 31% for placebo in IBS-D patients with bloating and pain 1, 2
  • Alternative systemically-absorbed antibiotics can be considered but require careful patient selection 2
  • Hydrogen-based breath testing with glucose or lactulose can confirm SIBO diagnosis before treatment 2, 5

Third-Line Treatment: Pharmacologic Agents

  • The American Gastroenterological Association suggests linaclotide 145 mcg once daily on an empty stomach for constipation-predominant symptoms with bloating, producing rapid improvement in bowel habits, bloating, and quality of life 6
  • Tricyclic antidepressants provide benefit for chronic abdominal pain and functional GI symptoms in IBD patients 8
  • Never use opiates for chronic abdominal pain management—they increase risk of dependence, overdose, and worsen GI symptoms long-term 8, 9

Adjunctive Therapies

  • The European Society for Pediatric Gastroenterology, Hepatology and Nutrition recommends gut-directed hypnotherapy, cognitive behavioral therapy, and mindfulness therapy for IBS symptoms 1, 2, 8, 9
  • These approaches are particularly valuable when symptoms impair quality of life despite medical management 8, 9

Special Considerations for IBD Patients

  • The American Gastroenterological Association recommends optimizing disease-directed therapy first before treating symptoms in IBD patients 5, 9
  • SIBO occurs in up to 30% of Crohn's disease patients, particularly with stricturing/fistulizing phenotype or loss of ileocecal valve 5
  • Consider bile acid malabsorption with bile acid sequestrants in patients with ileal disease or resection 5, 9
  • Pancreatic enzyme replacement may be needed if pancreatic exocrine insufficiency is suspected 5, 7, 9

When to Escalate Care

  • Refer to gastroenterology with motility expertise if symptoms persist despite 12 weeks of optimized therapy 6
  • Severe nausea, vomiting, or weight loss suggest gastroparesis or chronic intestinal pseudo-obstruction requiring antroduodenal manometry or wireless motility capsule 3
  • Severe constipation with bloating warrants anorectal manometry to diagnose pelvic floor dyssynergia 1, 2, 3
  • In women ≥50 years with new-onset bloating and abdominal fullness, maintain high suspicion for ovarian cancer and obtain appropriate imaging 1, 3